Prevention of Oral Carcinogenesis in Rats by Dracaena Cinnabari Resin Extracts

Overview

Journal Clin Oral Investig

Specialty Dentistry

Date 2018 Oct 7

PMID 30291495

Citations 7

Authors

Nashwan Al-Afifi

Aied Alabsi

Fahmi Kaid

Marina Bakri

Anand Ramanathan

Affiliations

Soon will be listed here.

Abstract

Objectives: In vivo study was performed to determine the chemopreventive efficacy of the DC resin methanol extract on a 4-nitroquinoline-1-oxide (4NQO) oral cancer animal model.

Materials And Methods: This study involves administration of 4NQO solution for 8 weeks alone (cancer induction) or with Dracaena cinnabari (DC) extract at 100, 500, and 1000 mg/kg. DC extract administration started 1 week before exposure until 1 week after the carcinogen exposure was stopped. All rats were sacrificed after 22 weeks, and histological analysis was performed to assess any incidence of pathological changes. Immunohistochemical expressions of selected tumor marker antibodies were analyzed using an image analyzer computer system, and the expression of selected genes involved in apoptosis and proliferative mechanism related to oral cancer were evaluated using RT-PCR.

Results: The incidence of OSCC decreased with the administration of DC extract at 100, 500, and 1000 mg/kg compared to the induced cancer group. The developed tumor was also observed to be smaller when compared to the induced cancer group. The DC 1000 mg/kg group inhibits the expression of Cyclin D1, Ki-67, Bcl-2, and p53 proteins. It was observed that DC 1000 mg/kg induced apoptosis by upregulation of Bax and Casp3 genes and downregulation of Tp53, Bcl-2, Cox-2, Cyclin D1, and EGFR genes when compared to the induced cancer group.

Conclusions: The data indicated that systemic administration of the DC resin methanol extract has anticarcinogenic potency on oral carcinogenesis.

Clinical Relevance: Chemoprevention with DC resin methanol extract may significantly reduce morbidity and possibly mortality from OSCC.

Citing Articles

Three-Dimensional Printing of an Apigenin-Loaded Mucoadhesive Film for Tailored Therapy to Oral Leukoplakia and the Chemopreventive Effect on a Rat Model of Oral Carcinogenesis.

Takashima H, Tagami T, Kato S, Pae H, Ozeki T, Shibuya Y Pharmaceutics. 2022; 14(8).

PMID: 36015201 PMC: 9415331. DOI: 10.3390/pharmaceutics14081575.

Development of a traditional Chinese medicine-based agent for the treatment of cancer cachexia.

Wu K, Chu P, Cheng Y, Li C, Tian J, Wu H J Cachexia Sarcopenia Muscle. 2022; 13(4):2073-2087.

PMID: 35718751 PMC: 9397559. DOI: 10.1002/jcsm.13028.

Periodontal disease affects oral cancer progression in a surrogate animal model for tobacco exposure.

Spuldaro T, Wagner V, Nor F, Gaio E, Squarize C, Carrard V Int J Oncol. 2022; 60(6.

PMID: 35514311 PMC: 9097773. DOI: 10.3892/ijo.2022.5367.

Hepatocyte Growth Factor Overexpression Slows the Progression of 4NQO-Induced Oral Tumorigenesis.

He X, Chen S, Tang Y, Zhao X, Yan L, Wu L Front Oncol. 2021; 11:756479.

PMID: 34970484 PMC: 8712676. DOI: 10.3389/fonc.2021.756479.

Plant-Based Antioxidant Extracts and Compounds in the Management of Oral Cancer.

Prakash S, Radha , Kumar M, Kumari N, Thakur M, Rathour S Antioxidants (Basel). 2021; 10(9).

PMID: 34572990 PMC: 8466097. DOI: 10.3390/antiox10091358.

References

Xie X, Clausen O, De Angelis P, Boysen M . The prognostic value of spontaneous apoptosis, Bax, Bcl-2, and p53 in oral squamous cell carcinoma of the tongue. Cancer. 1999; 86(6):913-20. DOI: 10.1002/(sici)1097-0142(19990915)86:6<913::aid-cncr4>3.0.co;2-a. View

Schwartz J . Biomarkers and molecular epidemiology and chemoprevention of oral carcinogenesis. Crit Rev Oral Biol Med. 2000; 11(1):92-122. DOI: 10.1177/10454411000110010501. View

Takeuchi S, Nakanishi H, Yoshida K, Yamamoto S, Tonoki H, Tsukamoto T . Isolation of differentiated squamous and undifferentiated spindle carcinoma cell lines with differing metastatic potential from a 4-nitroquinoline N-Oxide-induced tongue carcinoma in a F344 rat. Jpn J Cancer Res. 2000; 91(12):1211-21. PMC: 5926306. DOI: 10.1111/j.1349-7006.2000.tb00907.x. View

Gottesman M . Mechanisms of cancer drug resistance. Annu Rev Med. 2002; 53:615-27. DOI: 10.1146/annurev.med.53.082901.103929. View

Carelle N, Piotto E, Bellanger A, Germanaud J, Thuillier A, Khayat D . Changing patient perceptions of the side effects of cancer chemotherapy. Cancer. 2002; 95(1):155-63. DOI: 10.1002/cncr.10630. View

Tumuluri V, Thomas G, Fraser I . Analysis of the Ki-67 antigen at the invasive tumour front of human oral squamous cell carcinoma. J Oral Pathol Med. 2002; 31(10):598-604. DOI: 10.1034/j.1600-0714.2002.00042.x. View

Sporn M . Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer Res. 1976; 36(7 PT 2):2699-702. View

Reddy L, Odhav B, Bhoola K . Natural products for cancer prevention: a global perspective. Pharmacol Ther. 2003; 99(1):1-13. DOI: 10.1016/s0163-7258(03)00042-1. View

Yoshida K, Hirose Y, Tanaka T, Yamada Y, Kuno T, Kohno H . Inhibitory effects of troglitazone, a peroxisome proliferator-activated receptor gamma ligand, in rat tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide. Cancer Sci. 2003; 94(4):365-71. PMC: 11160187. DOI: 10.1111/j.1349-7006.2003.tb01448.x. View

10.

Soria J, Kim E, Fayette J, Lantuejoul S, Deutsch E, Hong W . Chemoprevention of lung cancer. Lancet Oncol. 2003; 4(11):659-69. DOI: 10.1016/s1470-2045(03)01244-0. View

11.

Tang X, Knudsen B, Bemis D, Tickoo S, Gudas L . Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin Cancer Res. 2004; 10(1 Pt 1):301-13. DOI: 10.1158/1078-0432.ccr-0999-3. View

12.

Mercer W . Cell cycle regulation and the p53 tumor suppressor protein. Crit Rev Eukaryot Gene Expr. 1992; 2(3):251-63. View

13.

Ribeiro D, Salvadori D, da Silva R, Ribeiro Darros B, Marques M . Genomic instability in non-neoplastic oral mucosa cells can predict risk during 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Oral Oncol. 2004; 40(9):910-5. DOI: 10.1016/j.oraloncology.2004.04.010. View

14.

Chin D, Boyle G, Theile D, Parsons P, Coman W . Molecular introduction to head and neck cancer (HNSCC) carcinogenesis. Br J Plast Surg. 2004; 57(7):595-602. DOI: 10.1016/j.bjps.2004.06.010. View

15.

Mothana R, Lindequist U . Antimicrobial activity of some medicinal plants of the island Soqotra. J Ethnopharmacol. 2004; 96(1-2):177-81. DOI: 10.1016/j.jep.2004.09.006. View

16.

Yamamoto K, Kitayama W, Denda A, Morisaki A, Kuniyasu H, Inoue M . Suppressive effects of a selective cyclooxygenase-2 inhibitor, etodolac, on 4-nitroquinoline 1-oxide-induced rat tongue carcinogenesis. Exp Toxicol Pathol. 2005; 56(3):145-51. DOI: 10.1016/j.etp.2004.07.001. View

17.

Yoshida K, Tanaka T, Hirose Y, Yamaguchi F, Kohno H, Toida M . Dietary garcinol inhibits 4-nitroquinoline 1-oxide-induced tongue carcinogenesis in rats. Cancer Lett. 2005; 221(1):29-39. DOI: 10.1016/j.canlet.2004.08.016. View

18.

Wang Z . The role of COX-2 in oral cancer development, and chemoprevention/ treatment of oral cancer by selective COX-2 inhibitors. Curr Pharm Des. 2005; 11(14):1771-7. DOI: 10.2174/1381612053764887. View

19.

Kanojia D, Vaidya M . 4-nitroquinoline-1-oxide induced experimental oral carcinogenesis. Oral Oncol. 2006; 42(7):655-67. DOI: 10.1016/j.oraloncology.2005.10.013. View

20.

Khan N, Afaq F, Saleem M, Ahmad N, Mukhtar H . Targeting multiple signaling pathways by green tea polyphenol (-)-epigallocatechin-3-gallate. Cancer Res. 2006; 66(5):2500-5. DOI: 10.1158/0008-5472.CAN-05-3636. View